Skip to content

Development and Validation of a Digital Pain-Reduction Kit for Musculoskeletal Injuries

CompletedNot applicableNCT03187132
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

This study will test the effectiveness of an evidence-based, multi-modal, "digital pain-reduction kit" as a non-pharmacological supplement to managing patients with pain due to musculoskeletal injuries. Outpatients will be randomized to receive either the pain reduction kit or active control. The kit will contain a virtual reality (VR) headset, therapeutic VR visualization software, and a low-cost wearable transcutaneous electrical nerve stimulation (TENS) unit. Clinical staff will monitor progress and provide scheduled coaching and outreach to patients in the intervention group. The control group will receive the low-cost wearable transcutaneous electrical nerve stimulation (TENS) unit alone; they will not receive VR or remote coaching. Study devices will be delivered to the patient's home with instructions for use; patients will receive remote clinical and technical support. Patients will be followed for 60 days and monitored for functional status, pain levels, use of pain medications (including opioids), satisfaction with care, and time to returning to work.

Study details

Official title
Development and Validation of a Digital Pain-Reduction Kit for Musculoskeletal Injuries
Interventions
  • Device: Digital Pain Reduction Kit
  • Device: Active Control
Sponsor
Cedars-Sinai Medical Center
Collaborators
Travelers; Samsung; AppliedVR Inc.; Bayer; Hollywog
Start date
2018-04-03
Primary completion
2020-05-20
Sex
All
Age range
from 18 Years
Results posted
Yes, on ClinicalTrials.gov
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Provision of signed and dated informed consent form 2. Stated willingness to comply with all study procedures and availability for the duration of the study 3. Male or female, age 18 or older 4. Seeking care for a musculoskeletal injury 5. Experiencing pain greater than 3 out of 10 on a visual analog scale 6. English or Spanish speaking 7. Owns a compatible Android or iOS smartphone device (excluding tablets) Exclusion Criteria: 1. Unable to understand the goals of the study due to cognitive difficulty 2. Use of a cardiac pacemaker, implanted defibrillator, or other implanted metallic or electronic device or high-frequency surgical equipment. (contraindication for TENS units) 3. Pregnant (contraindication for TENS unit) 4. Current diagnosis of epilepsy, dementia, or other neurological disease that may prevent use of VR hardware or software 5. Hypersensitivity to flashing light or motion 6. Injury to the eyes, face, neck, or arms that prevents comfortable use of VR hardware or software, or safe use of other study hardware (e.g., open sores, wounds, or skin rash on face)

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03187132